How has the field of metastatic breast cancer in bones evolved over the past 22 years?
Background: Although knowledge on metastatic breast cancer in bones (MBCB) has increased rapidly over the past 22 years, a comprehensive and objective bibliometric analysis is still lacking. Materials and methods: We used R, VOSviewer, and Citespace software to conduct a bibliometric analysis of 5,4...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-06-01
|
| Series: | Journal of Bone Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2212137423000131 |
| _version_ | 1797809849122160640 |
|---|---|
| author | Yi Chen Zhen-Ning Guo Rong-Quan He Zhi-Guang Huang Jia-Yuan Luo Wei Tang Su-Ning Huang Gang Chen |
| author_facet | Yi Chen Zhen-Ning Guo Rong-Quan He Zhi-Guang Huang Jia-Yuan Luo Wei Tang Su-Ning Huang Gang Chen |
| author_sort | Yi Chen |
| collection | DOAJ |
| description | Background: Although knowledge on metastatic breast cancer in bones (MBCB) has increased rapidly over the past 22 years, a comprehensive and objective bibliometric analysis is still lacking. Materials and methods: We used R, VOSviewer, and Citespace software to conduct a bibliometric analysis of 5,497 papers on MBCB from the Web of Science Core Collection (WOSCC) using author, institution, country/region, citation, and keyword indicators. Results: A general strong sense of scholarly collaboration was noted in the MBCB field at the author, research institution, and country/region levels. We discovered some outstanding authors and highly productive institutions, but with less collaboration with other academic groups. Unbalanced and uncoordinated developments were observed among countries/regions in the field of MBCB research. We also found that by using various indicators and applying different analysis methods to them, we were able to broadly identify primary clinical practices, relevant clinical experiments, and directions for bioinformatics regarding MBCB, changes over the past 22 years, and current challenges in the field. The development of knowledge on MBCB is progressing greatly; however, MBCB is still incurable. Conclusion: This study is the first to use bibliometrics to provide an overall analysis of the scientific output of MBCB studies. Palliative therapies for MBCB are mostly in a mature state. However, research on the molecular mechanisms and immune response to tumors related to the development of treatments to cure MBCB remains relatively immature. Therefore, further research should be undertaken in this area. |
| first_indexed | 2024-03-13T06:59:04Z |
| format | Article |
| id | doaj.art-6e880b72fcc74b01be6d62766954b061 |
| institution | Directory Open Access Journal |
| issn | 2212-1374 |
| language | English |
| last_indexed | 2024-03-13T06:59:04Z |
| publishDate | 2023-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of Bone Oncology |
| spelling | doaj.art-6e880b72fcc74b01be6d62766954b0612023-06-07T04:47:59ZengElsevierJournal of Bone Oncology2212-13742023-06-0140100480How has the field of metastatic breast cancer in bones evolved over the past 22 years?Yi Chen0Zhen-Ning Guo1Rong-Quan He2Zhi-Guang Huang3Jia-Yuan Luo4Wei Tang5Su-Ning Huang6Gang Chen7Department of Pathology, First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Road Nanning, Guangxi Zhuang Autonomous Region 530021, PR ChinaDepartment of Pathology, First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Road Nanning, Guangxi Zhuang Autonomous Region 530021, PR ChinaDepartment of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Road Nanning, Guangxi Zhuang Autonomous Region 530021, PR ChinaDepartment of Pathology, First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Road Nanning, Guangxi Zhuang Autonomous Region 530021, PR ChinaDepartment of Pathology, First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Road Nanning, Guangxi Zhuang Autonomous Region 530021, PR ChinaDepartment of Breast Surgery, Guangxi Medical University Cancer Hospital, No. 71 Hedi Rd, Nanning, Guangxi Zhuang Autonomous Region, 530021, PR ChinaDepartment of Radiotherapy, Guangxi Medical University Cancer Hospital, No. 71 Hedi Rd, Nanning, Guangxi Zhuang Autonomous Region, 530021, PR ChinaDepartment of Pathology, First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Road Nanning, Guangxi Zhuang Autonomous Region 530021, PR China; Corresponding author.Background: Although knowledge on metastatic breast cancer in bones (MBCB) has increased rapidly over the past 22 years, a comprehensive and objective bibliometric analysis is still lacking. Materials and methods: We used R, VOSviewer, and Citespace software to conduct a bibliometric analysis of 5,497 papers on MBCB from the Web of Science Core Collection (WOSCC) using author, institution, country/region, citation, and keyword indicators. Results: A general strong sense of scholarly collaboration was noted in the MBCB field at the author, research institution, and country/region levels. We discovered some outstanding authors and highly productive institutions, but with less collaboration with other academic groups. Unbalanced and uncoordinated developments were observed among countries/regions in the field of MBCB research. We also found that by using various indicators and applying different analysis methods to them, we were able to broadly identify primary clinical practices, relevant clinical experiments, and directions for bioinformatics regarding MBCB, changes over the past 22 years, and current challenges in the field. The development of knowledge on MBCB is progressing greatly; however, MBCB is still incurable. Conclusion: This study is the first to use bibliometrics to provide an overall analysis of the scientific output of MBCB studies. Palliative therapies for MBCB are mostly in a mature state. However, research on the molecular mechanisms and immune response to tumors related to the development of treatments to cure MBCB remains relatively immature. Therefore, further research should be undertaken in this area.http://www.sciencedirect.com/science/article/pii/S2212137423000131Breast cancerBone metastasisBibliometricsTargeted therapyImmunotherapyBioinformatics |
| spellingShingle | Yi Chen Zhen-Ning Guo Rong-Quan He Zhi-Guang Huang Jia-Yuan Luo Wei Tang Su-Ning Huang Gang Chen How has the field of metastatic breast cancer in bones evolved over the past 22 years? Journal of Bone Oncology Breast cancer Bone metastasis Bibliometrics Targeted therapy Immunotherapy Bioinformatics |
| title | How has the field of metastatic breast cancer in bones evolved over the past 22 years? |
| title_full | How has the field of metastatic breast cancer in bones evolved over the past 22 years? |
| title_fullStr | How has the field of metastatic breast cancer in bones evolved over the past 22 years? |
| title_full_unstemmed | How has the field of metastatic breast cancer in bones evolved over the past 22 years? |
| title_short | How has the field of metastatic breast cancer in bones evolved over the past 22 years? |
| title_sort | how has the field of metastatic breast cancer in bones evolved over the past 22 years |
| topic | Breast cancer Bone metastasis Bibliometrics Targeted therapy Immunotherapy Bioinformatics |
| url | http://www.sciencedirect.com/science/article/pii/S2212137423000131 |
| work_keys_str_mv | AT yichen howhasthefieldofmetastaticbreastcancerinbonesevolvedoverthepast22years AT zhenningguo howhasthefieldofmetastaticbreastcancerinbonesevolvedoverthepast22years AT rongquanhe howhasthefieldofmetastaticbreastcancerinbonesevolvedoverthepast22years AT zhiguanghuang howhasthefieldofmetastaticbreastcancerinbonesevolvedoverthepast22years AT jiayuanluo howhasthefieldofmetastaticbreastcancerinbonesevolvedoverthepast22years AT weitang howhasthefieldofmetastaticbreastcancerinbonesevolvedoverthepast22years AT suninghuang howhasthefieldofmetastaticbreastcancerinbonesevolvedoverthepast22years AT gangchen howhasthefieldofmetastaticbreastcancerinbonesevolvedoverthepast22years |